Starting the medication, and the doctor visits that come with it, is simply when it gets diagnosed
Pharma Industry 2 min read Novo Nordisk to launch lower-cost Ozempic copy in South Africa The medicine, which uses the same semaglutide active ingredient as Ozempic, will launch on July 27 and is registered by the South African Health Products Regulatory Authority (SAHPRA) as the country's only authorised semaglutide copy, the Danish drugmaker said in a statement late on Thursday
For example, a reported case involved a patient injecting 0.5 milliliters instead of the intended 0.05 milliliters, resulting in a tenfold overdose
Discovery Phase (Several Months to Years): This is often the longest phase, where both sides exchange information, conduct depositions, and gather expert testimonies
Emerging GLP-1 options and future coverage possibilities The GLP-1 landscape is evolving rapidly, and emerging alternatives may offer new insurance coverage opportunities